ライフサイエンスコーパス: Medicaid

1 s or patients eligible for both Medicare and Medicaid).

2 program to pay for PrEP (12% versus 45% for Medicaid).

3 Most women (74.2%) were insured through Medicaid.

4 fordable Care Act's (ACA) state expansion of Medicaid.

5 d private insurance and 981 (78.8%) accepted Medicaid.

6 vascular disease (CVD), through Medicare and Medicaid.

7 -of-pocket spending as those continuously on Medicaid.

8 ts (35-80 years old) were on Medicare and/or Medicaid.

9 ved in states that did versus did not expand Medicaid.

10 re plans operating prior to 2014, 106 exited Medicaid.

11 ; aHR(Optum) 0.84, 0.65-1.08; glyburide: aHR(Medicaid) 0.87, 0.74-1.03; aHR(Optum) 1.11, 0.86-1.42).

12 could not exclude the null (glimepiride: aHR(Medicaid) 1.17, 95% CI 0.96-1.42; aHR(Optum) 0.84, 0.65-

13 (89% vs. 63%), and were primarily insured by Medicaid (38%) or uninsured (35%).

14 A substantial minority was on Medicaid (41%).

15 ment health insurance other than Medicare or Medicaid (43.2%) vs among those without health insurance

16 nsurance, $200 million (9.6%) for those with Medicaid, $48 million (2.3%) for those with Medicare, an

17 continuous coverage (commercial/Medicare or Medicaid) 6 months prior to and after the first CHB diag

18 nts with DU-IE were predominantly insured by Medicaid (68.3% vs 13.4% for non-DU-IE), they had higher

19 DU-IE patients were predominantly insured by Medicaid (68.3% vs 13.4%, P < 0.001).

20 h Massachusetts having a large proportion of Medicaid (75%) and EU and New York having large proporti

21 care coverage in 2012-2015, transitioning to Medicaid (adjusted prevalence ratio, 0.95 [0.87, 1.04])

22 e-crossover design and 2013-2017 Mississippi Medicaid administrative claims data.

23 uously enrolled in coverage from the Alabama Medicaid Agency from birth between 2008 and 2012, adjust

24 Reevaluation of Medicaid alcohol use policies may be warranted, to align

25 ted with decreased proportion of LTs paid by Medicaid among patients with ALD post-2011.

26 ion (95% confidence interval) of LTs paid by Medicaid among restrictive versus unrestrictive states b

27 nce Contract for the Elderly (1999-2002) and Medicaid Analytic eXtract (2000-2007) databases (United

28 nce Contract for the Elderly (1999-2002) and Medicaid Analytic eXtract (2000-2007) databases (United

29 Using the United States Medicaid Analytic eXtract (MAX) dataset, we conducted a

30 HUU comparison data were obtained from the Medicaid Analytic Extract database, restricted to states

31 d their offspring nested in the 2000-2013 US Medicaid Analytic eXtract, we contrasted time trends in

32 years before implementation of Medicare and Medicaid and 12.7 per 100 persons in the 4 years after (

33 uninsured-self-pay contacts, whereas 27% of Medicaid and 41% of uninsured-self-pay contacts were off

34 induction was 8 days (IQR, 4 to 15 days) for Medicaid and 7 days (IQR, 3 to 14 days) for uninsured-se

35 45.0% are likely to enroll in their state's Medicaid and Children's Health Insurance Program, and 47

36 Discounts increased from 40% to 76% in Medicaid and from 23% to 51% for other payers.

37 rea users, and 714 and 385 SCA/VA events, in Medicaid and Optum, respectively.

38 ncluded list and net prices and discounts in Medicaid and other payers.

39 I hospitalizations were identified as having Medicaid and private insurance, respectively.

40 s study aims to characterize how UCCs manage Medicaid and privately insured patients who present with

41 The Centers for Medicare and Medicaid and The Joint Commission have specified the inc

42 Hospital Medicaid and uninsured patients were categorized into sa

43 Whether increases in Medicaid and uninsured payor mix impact hospital perform

44 63 pregnancies in women who were enrolled in Medicaid and who delivered a live-born infant between 20

45 dental visits for young children enrolled in Medicaid and, in fact, offers evidence that increased me

46 of patients dually eligible for Medicare and Medicaid) and high medical risk (defined as practices in

47 Sixty-one percent were enrolled in Medicaid, and 95% resided in urban communities.

48 ults who were randomly selected to apply for Medicaid, and data collected through in-person health sc

49 vels (20%, 50%), insurance groups (Medicare, Medicaid, and dual-eligible), and beneficiary characteri

50 ded no insurance, insurance with Medicare or Medicaid, and features associated with higher bleeding r

51 ceiving healthcare coverage from commercial, Medicaid, and Medicare payers.

52 , whereas those covered by Managed Medicare, Medicaid, and Medicare received 31%, 24%, and 11% less i

53 th data supplemented by linkage to Medicare, Medicaid, and National Death Index data from 2001 throug

54 he higher charges, proportion of patients on Medicaid, and rates of leaving against medical advice am

55 he higher charges, proportion of patients on Medicaid, and rates of leaving AMA among the DU-IE group

56 Uninsured (aOR 0.41; P = .009) and Medicare/Medicaid (aOR 0.92; P < .001) patients had less outpatie

57 Medicare (aOR, 0.79 [0.72-0.86]), Medicaid (aOR, 0.52 [0.46-0.58]), and uninsured patients

58 < 0.001), black (15.0% vs 7.6%, P < 0.001), Medicaid beneficiaries (22.0% vs 6.4%, P < 0.001), and i

59 Medicaid beneficiaries enrolled in exiting plans had acc

60 the total number of prescriptions among all Medicaid beneficiaries increased, with gains of 89.7% in

61 o extract filled prescription rates per 1000 Medicaid beneficiaries of statins, antihypertensives, P2

62 cularization and in-hospital mortality among Medicaid beneficiaries versus privately insured individu

63 In unadjusted analyses, Medicaid beneficiaries with STEMI had lower rates of cor

64 Medicaid beneficiaries with STEMI had lower rates of rev

65 creases in quarterly prescriptions (per 1000 Medicaid beneficiaries) of statins (DID estimate [95% CI

66 These exiting plans enrolled 4848310 Medicaid beneficiaries, with a mean of 606039 beneficiar

67 n of cardiovascular prescription drugs among Medicaid beneficiaries.

68 The Medicaid CHB cohort was the sickest (DCCI, 2.6, P < 0.00

69 As compared with those not enrolled in Medicaid, children in the Medicaid group were significan

70 ncident user cohort studies using five-state Medicaid claims (1999-2012) and Optum Clinformatics comm

71 All data were linked to Medicare and Medicaid claims and pharmaceutical data.

72 o published reports of an HIV algorithm from Medicaid claims codes that have been compared with an HI

73 as performed using the MarketScan multistate Medicaid claims database (2013-2017), covering 12 millio

74 Using Medicaid claims from 38 states from 2006 to 2014, we con

75 This was a retrospective cohort study using Medicaid clinical encounter and pharmacy billing records

76 was significantly increased in patients with Medicaid compared with private insurance (RR, 1.36; 95%

77 o, 1.35; 95% CI, 1.26-1.45) were observed in Medicaid compared with private insurance, despite extens

78 icy scenarios for adults within Medicare and Medicaid, compared to a base case of no new intervention

79 interquartile range [IQR], 2 to 10 days) for Medicaid contacts and 5 days (IQR, 1 to 9 days) for unin

80 linicians offered new appointments to 54% of Medicaid contacts and 62% of uninsured-self-pay contacts

81 ves for healthier foods through Medicare and Medicaid could generate substantial health gains and be

82 able Care Act, there was a 4.75% increase in medicaid coverage and a 1.91% decrease in the uninsured.

83 high adherence, and those with dual Medicare/Medicaid coverage and more cardiologist visits after dis

84 reliant" if they were uninsured or had only Medicaid coverage at dialysis onset and had not qualifie

85 Individuals who spend-down to Medicaid coverage have 4x the out-of-pocket spending as

86 ioid use was also associated with older age, Medicaid coverage, residency outside of the Northeast, i

87 In unadjusted models, poverty, Medicaid coverage, self-identifying as black, and obesit

88 g active heroin use, particularly those with Medicaid coverage.

89 scharge data (1995 through 2014 or 2015) and Medicaid data (1999 through 2009).

90 has the potential to improve the utility of Medicaid data for assessing health outcomes and programm

91 the potential to improve the utility of the Medicaid data for assessing health outcomes and programm

92 that could identify PLWDH in New York State Medicaid data from 2006-2014 and 2) validate this algori

93 orithm that could identify PLWDH in New York Medicaid data from 2006-2014; and 2) validate this algor

94 This pharmacoepidemiology study uses Medicaid data to estimate associations between first-tri

95 Using Mississippi Medicaid data, we examined the association of transient

96 uman immunodeficiency virus (HIV) (PLWDH) in Medicaid data.

97 ons living with diagnosed HIV (PLWDH) in the Medicaid data.

98 have not expanded Medicaid or do not provide Medicaid dental benefits for adults.

99 We used the publicly available Medicaid Drug Utilization and Current Population Survey

100 This study uses Medicaid drug utilization data to describe reimbursement

101 ayment reform, whereas Hispanic and Medicare/Medicaid dual-eligible patients experienced slight decre

102 icare beneficiaries who are also enrolled in Medicaid (dually enrolled beneficiaries) have drawn the

103 The Affordable Care Act expanded Medicaid eligibility allowing low-income individuals gre

104 The expansion of Medicaid eligibility under the Affordable Care Act is a

105 ministrative data sources, identifying 7,525 Medicaid-eligible adults.

106 ducted a population-based study of 1,753,865 Medicaid-eligible pregnancies between January 2000 and D

107 tive annual (July-June) cohorts of Tennessee Medicaid-enrolled children (2006-2014) from birth throug

108 ed a retrospective cohort study of Tennessee Medicaid enrollees age >=18 years initiating long-acting

109 antiretroviral therapy (ART) reinitiation in Medicaid enrollees.

110 ad exposure include race/ethnicity, poverty, Medicaid enrollment, housing built before 1950, and age.

111 ring the 2 years after implementation of the Medicaid expansion (2014 and 2015) relative to the 4 yea

112 ites in either state group following the ACA Medicaid expansion (early adopter, 1.12 [95% CI, 0.98-1.

113 he utilization and outcomes of surgery after Medicaid Expansion (ME) for patients with peripheral art

114 eye examination within the past year due to Medicaid expansion 1, 2, 3, and 4 cumulative years after

115 Medicaid expansion among previously uninsured individual

116 1157 patients from early-adopter states (ACA Medicaid expansion by January 2014) and 785 patients fro

117 Perhaps most important, the Medicaid expansion extended coverage to millions of low-

118 However, the uptake of state Medicaid expansion has been variable.

119 Medicaid expansion has raised concerns over the influx o

120 eye examinations from years before and after Medicaid expansion implementation.

121 Medicaid expansion is a potential mechanism for expandin

122 Implementation of Medicaid expansion policies was associated with a 1.3% (

123 Medicaid expansion policies were significantly associate

124 in Medicaid expansion states relative to non-Medicaid expansion states and changes in relative dispar

125 r black infants relative to white infants in Medicaid expansion states compared with nonexpansion sta

126 s to compare birth outcomes among infants in Medicaid expansion states relative to non-Medicaid expan

127 Persons who inject drugs in Medicaid expansion states were more likely to have insur

128 ially among low-income people who resided in Medicaid expansion states.

129 State Medicaid expansion status and racial/ethnic category.

130 ls (CIs) were used to examine differences by Medicaid expansion status in indicators of healthcare ac

131 ong persons who inject drugs (PWID) by state Medicaid expansion status.

132 Medicaid expansion under the Affordable Care Act increas

133 The 2014 Medicaid expansion was associated with a significant inc

134 Medicaid expansion was associated with increased insuran

135 Medicaid expansion was associated with significantly gre

136 It remains unclear how the Medicaid expansion was associated with the temporal tren

137 Medicaid expansion was not associated with an increase i

138 Medicaid expansion was not associated with an increase i

139 The Medicaid expansion was not associated with higher direct

140 Based on data from 2011-2016, state Medicaid expansion was not significantly associated with

141 d type of ED visits in the first year of ACA Medicaid expansion were found, suggesting that expansion

142 Characterizing the association of Medicaid expansion with hospitalization after injury is

143 performed to compare the association of the Medicaid expansion with per-capita cardiovascular drug p

144 Following the ACA Medicaid expansion, the proportional change in rate incr

145 alize hospitals with increased SNB following Medicaid expansion.

146 s before and after the Affordable Care Act's Medicaid expansion.

147 patients had to be continuously enrolled in Medicaid for 6 months after buprenorphine discontinuatio

148 (16.5%) were dually enrolled in Medicare and Medicaid for at least 1 month.

149 se not enrolled in Medicaid, children in the Medicaid group were significantly more likely (after adj

150 for confounders, whites with OAG enrolled in Medicaid had 198% higher odds of receiving no glaucoma t

151 of patients dually eligible for Medicare and Medicaid had significantly lower MIPS scores compared wi

152 Patients with medicaid had the greatest reduction in mortality (5.71%)

153 r, considerably lower reimbursement rates of Medicaid have raised concerns on the unintended conseque

154 Children aged 5 to 19 enrolled in Medicaid in 2009 to 2010 were included.

155 a mechanism to encourage enrollment; expand Medicaid in all states; and establish a public insurance

156 The Center for Medicare and Medicaid Innovation launched the Bundled Payments for Ca

157 At multivariable analysis, Medicaid insurance (odds ratio, 3.68; 95% confidence int

158 y associated with longer wait times included Medicaid insurance [odds ratio (OR) 3.02; 95% confidence

159 Complex patients with Medicaid insurance are experiencing the longest delay de

160 ignificantly higher proportion of Blacks had Medicaid insurance compared to Whites (40% versus 20%, p

161 ortion of patients who are nonwhite and have Medicaid insurance coverage ( P<0.001 for all).

162 Hispanic race, Asian race, Medicaid insurance, and no insurance associated inversel

163 tors for OUD included younger age, male sex, Medicaid insurance, Medicare insurance, higher number of

164 Age <65 years; Medicare or Medicaid insurance; nonalcoholic etiology of cirrhosis;

165 County, had a diagnosis of asthma, and were Medicaid insured were studied.

166 Uninsured and Medicaid-insured adults aged 18 to 64 years.

167 In a population of primarily Medicaid-insured pregnant women managed by a cardio-obst

168 Medicaid is integral to public health because it insures

169 Among the Centers for Medicare and Medicaid-linked patients, the HF rehospitalization rate

170 We critically reviewed 32 studies on Medicaid managed care (2011-2019).

171 Retrospective cohort of all comprehensive Medicaid managed care plans (N = 390) during the interva

172 Of the 366 comprehensive Medicaid managed care plans operating prior to 2014, 106

173 cause of high overhead in their Medicare and Medicaid managed-care plans.

174 r quality with implementation or redesign of Medicaid managed-care programs.

175 ty or patient experience in the plans in the Medicaid market.

176 third-party payer, classified as commercial, Medicaid, Medicare, manufacturer assistance program, or

177 d significantly more in states that expanded Medicaid (n = 32) compared with nonexpansion states (n =

178 rict of Columbia and 18 states that expanded Medicaid (n = 8 530 751) and 17 states that did not (n =

179 t likely to have a readmission compared with Medicaid/no insurance and Medicare populations.

180 ADAPs, especially in the South and in Medicaid non-expansion states, should consider investing

181 ADAPs, especially in the South and in Medicaid nonexpansion states, should consider investing

182 in, particularly for minorities and those in Medicaid nonexpansion states.

183 efined expander states as those who expanded Medicaid on or before January 1, 2014, and nonexpander s

184 associated liver disease (ALD) is covered by Medicaid only with documentation of abstinence and/or al

185 Investigators posed as either a Medicaid or a privately-insured patient with symptoms of

186 ty of 20/40 or better (P = .027), and having Medicaid or being uninsured (P < .001) were significantl

187 pronounced in states that have not expanded Medicaid or do not provide Medicaid dental benefits for

188 x, race/ethnicity, disability, enrollment in Medicaid or low-income subsidies, managed care enrollmen

189 Medicaid or Medicare insurance, surgery at low and mediu

190 o acute respiratory distress syndrome, using Medicaid or Medicare, or, conversely, generous work bene

191 2012 to 2015 for STEMI hospitalizations with Medicaid or private insurance as primary payer.

192 unaffected group, P < 0.001) and covered by Medicaid or uninsured (16.3% vs 9.8% of unaffected group

193 (OR 0.52, P < 0.01) and those with Medicare/Medicaid (OR 0.79, P < 0.01) were less likely to receive

194 .1 +/- 11.1 years to 50.2 +/- 10.2 years for Medicaid (P < 0.001 for both).

195 ed over the lifetime of current Medicare and Medicaid participants (average simulated years = 18.3 ye

196 drugs is an ongoing concern for Medicare and Medicaid, particularly for patients with chronic health

197 ; however, the disparity between private and Medicaid patients remained.

198 direct-to-ED referral rates for private and Medicaid patients were 27.9% and 33.8%, respectively.

199 Medicaid patients were more likely to be referred direct

200 Medicaid patients were nearly 9 times more likely to hav

201 Medicaid patients were significantly more likely than pr

202 Medicaid plays an important role in the social safety ne

203 Restrictive Medicaid policies are present in most states with active

204 We categorized Medicaid policies for states as "restrictive" (requiring

205 We surveyed Medicaid policies in all states actively performing LT a

206 Different Medicaid policies may affect the distribution of LT for

207 t-2011 compared to states with unrestrictive Medicaid policies.

208 whether a 2012 change in the South Carolina Medicaid policy to reimburse hospitals for provision of

209 ith the greatest reduction identified in the medicaid population.

210 ith lower proportions of LTs for ALD paid by Medicaid post-2011 compared to states with unrestrictive

211 r adjusted proportion of LTs for ALD paid by Medicaid post-2011.

212 d to have 24 months continuous enrollment in Medicaid prior to the first antibiotic ear drop dispensi

213 th the future of the Affordable Care Act and Medicaid program unclear, it is critical to examine the

214 ed death among nonelderly individuals in the Medicaid program, focusing on decedents with and without

215 In the United States, state Medicaid programs pay for medical and dental care for ch

216 ependence, by using claims data from five US Medicaid programs supplemented with Medicare claims for

217 ket payments per 30 tablets were lower among Medicaid recipients ($3) than among those with Medicare

218 Nearly two-thirds of all Medicaid recipients are currently enrolled in a health m

219 ns with commercial health insurance and 3394 Medicaid recipients met the study inclusion criteria.

220 s, the difference in LOS for Medicaid vs non-Medicaid recipients varied significantly by state.

221 with those with commercial health insurance, Medicaid recipients were 234% more likely to not receive

222 Medicaid recipients who were the oldest ICU survivors (>

223 ns were 35%, 19%, and 30%, respectively, for Medicaid recipients.

224 ng long-term care among elderly and disabled Medicaid recipients.

225 We assumed no Medicaid reimbursement restrictions by fibrosis stage at

226 n of illness), public insurance (Medicare or Medicaid), residence in a low-income area, and obesity w

227 The Centers for Medicare and Medicaid Services (CMS) developed the Accountable Care O

228 Centers for Medicare & Medicaid Services (CMS) eligibility criteria for lung ca

229 Centers for Medicare and Medicaid Services (CMS) has proposed a rule change to re

230 he past decade, the Centers for Medicare and Medicaid Services (CMS) have led the nationwide shift to

231 established by the Centers for Medicare and Medicaid Services (CMS) in 2010 with a goal of reducing

232 he publicly available Centers for Medicare & Medicaid Services (CMS) Inventory Tool to determine the

233 cember of 2019, the Centers for Medicare and Medicaid Services (CMS) put out a notice of proposed rul

234 compliance with the Centers for Medicare and Medicaid Services (CMS) SEP-1 BCx component, 30-day read

235 ears according to the Centers for Medicare & Medicaid Services (CMS), and 74 years according to the N

236 efinition used by the Centers for Medicare & Medicaid Services and a case definition developed by the

237 ere mandated by the Centers for Medicare and Medicaid Services as a condition of reimbursement.

238 with PAD according to Centers for Medicare & Medicaid Services criteria.

239 iods were linked to Centers for Medicare and Medicaid Services data to compare 30-day death and unpla

240 Center for Medicare and Medicaid Services data were used to calculate associated

241 Reporting Tool and Centers for Medicare and Medicaid Services databases were queried for data on NIH

242 ance Survival and the Centers for Medicare & Medicaid Services dialysis facility database to identify

243 certified by the U.S. Centers for Medicare & Medicaid Services during the 2018-19 influenza season in

244 illance Network and Centers for Medicare and Medicaid Services ESRD death data from 2000 to 2013.

245 re obtained from the Center for Medicare and Medicaid Services Fee Schedule 2017 and published data.

246 The cost to the Centers for Medicare and Medicaid Services for eye drops prescribed for postopera

247 es established by the Centers for Medicare & Medicaid Services for Medicare beneficiaries in the Unit

248 ange plans from the Centers for Medicare and Medicaid Services for the 2016 enrollment year.

249 Medicare uses the Centers for Medicare & Medicaid Services Hierarchical Condition Category (CMS-H

250 Administration and Centers for Medicare and Medicaid Services in 2014, whereas CT colonography scree

251 ogram, enacted by the Centers for Medicare & Medicaid Services in response to the Protecting Access t

252 Two options of the Centers for Medicare and Medicaid Services Kidney Care Choices model-the Kidney C

253 g the patients with Centers for Medicare and Medicaid Services linkage data, the mortality at 30 days

254 presentation and the Centers for Medicare & Medicaid Services mandates administration within 3 hours

255 Accordingly, Centers for Medicare and Medicaid Services measures may unintentionally penalize

256 cohort meeting the Centers for Medicare and Medicaid Services measures.

257 The Centers for Medicare and Medicaid Services Medicare Part D Prescriber Public Use

258 The Centers for Medicare and Medicaid Services Medicare Part D Prescriber Public Use

259 der the new mandatory Centers for Medicare & Medicaid Services Merit-based Incentive Payment System (

260 and readmissions by the Centers for Medicare/Medicaid Services model, and therefore destined for a fi

261 ia in 2014 and either Centers for Medicare & Medicaid Services or Institute for Health Metrics and Ev

262 ons from 2 distinct Centers for Medicare and Medicaid Services policies.

263 It summarizes the Centers for Medicare & Medicaid Services process and requirements for referral

264 ves as the basis for a Center for Medicare & Medicaid Services program designed to evaluate the Milli

265 er 23, 2019, the US Centers for Medicare and Medicaid Services proposed 2 new standards that organ pr

266 RATIONALE: The Centers for Medicare and Medicaid Services recently implemented financial penalti

267 In 2017, the Centers for Medicare & Medicaid Services released a National Coverage Determina

268 The Centers for Medicare and Medicaid Services required large group practices to subm

269 The Centers for Medicare and Medicaid Services requires hospitals to report complianc

270 (95% CI, 694-724) of Centers for Medicare & Medicaid Services sepsis and 1,498 cases (95% CI, 1,471-

271 The Centers for Medicare & Medicaid Services should consider using the EDAC measure

272 and consistent with Centers for Medicare and Medicaid Services TC policies, the COMPASS model of TC w

273 age decision by the Centers for Medicare and Medicaid Services to only provide payment for allogeneic

274 ok-Up Tool from the Centers for Medicare and Medicaid Services was queried for each of the 20 top cod

275 Data from the Centers for Medicare and Medicaid Services were used to calculate the associated

276 actice liability, the Centers for Medicare & Medicaid Services' Medicare malpractice geographic pract

277 f Veterans Affairs, Centers for Medicare and Medicaid Services, and Centers for Disease Control and P

278 uding those used by Centers for Medicare and Medicaid Services, may not adequately account for patien

279 n September 2014 with Centers for Medicare & Medicaid Services, U.S.

280 cts of expansion on Centers for Medicare and Medicaid Services-endorsed Patient Safety Indicators (PS

281 Centers for Medicare and Medicaid Services-linked data were available in 63% of p

282 Among 12 212 Centers for Medicare and Medicaid Services-linked patients, there were no signifi

283 payers, such as the Center for Medicare and Medicaid Services.

284 btained through the Centers for Medicare and Medicaid Services.

285 volume according to Centers for Medicare and Medicaid Services.

286 nstitute of Texas and Centers for Medicare & Medicaid Services.

287 and were receiving Centers for Medicare and Medicaid Services.

288 nsfer data from the Centers for Medicare and Medicaid Services.

289 ata reported to the Centers for Medicare and Medicaid Services.

290 d is not covered by Centers for Medicare and Medicaid Services.PurposeTo report postapproval clinical

291 Administration; the Centers for Medicare and Medicaid Services; and commercial manufacturers of these

292 , Open Payments Data [Centers for Medicare & Medicaid Services]); regulations and legal actions of th

293 s ( P < 0.05) in baseline responses based on Medicaid status and race/ethnicity.

294 In a large cohort of youths insured by Medicaid, the use of SSRIs or SNRIs-the most commonly us

295 As states continue to expand Medicaid to the previously uninsured, providers may want

296 graphic variables, the difference in LOS for Medicaid vs non-Medicaid recipients varied significantly

297 d with white infants in states that expanded Medicaid vs those that did not.

298 ansion of health coverage since Medicare and Medicaid were enacted.

299 PCGs of children enrolled in Medicaid were significantly more likely to be the mother

300 ured) and Cohort 2 (includes Medicare and/or Medicaid) were randomized to alert activation in their e